Immune cells not only remember viruses, but can also secrete tumor-fighting antibodies, say Weizmann Institute researchers; ...

Aligning with the International Day for Biological Diversity's theme of "Acting locally for global impact," researchers have released a comprehensive blueprint for building a robust, globally ...

Atherosclerotic plaques form through lipid and immune cell accumulation beneath the arterial endothelium. CD8 (cluster of differentiation 8) T cells are abundant in lesions, and their activation ...

U.S. Olympic gold medal-winning athlete Lindsey Vonn is once again teaming up with infectious disease biopharma Invivyd for a new campaign centering on antibody-based treatments. The “Antibodies for ...

SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...

Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss—No Target Is Out of the Realm of Possibility Bispecific antibodies (bsAbs) have emerged as a novel ...

对于某个病原蛋白（target），使用突变引物构建质粒文库（plasmid_lib）。在 plasmid_lib 内部，每个 barcode 对应一个 variant ...

In this edition of the biotech bi-weekly, we reveal recent product launches enhancing microbial analysis, antibody isotype quantification and biologics development. Plus, we highlight the partnerships ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. When Laura Ehrlich gave birth to her ...

Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...

This fundamental manuscript presents a practical modification of the orthogonal hybridization chain reaction (HCR) technique, a promising yet underutilized method with broad potential for future ...